Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Danielian, P. S., White, R., Hoare, S. A., Fawell, S. E. & Parker, M. G. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol 7, 232–240, doi: 10.1210/mend.7.2.8469236 (1993).
2. Feil, R. et al. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 93, 10887–10890 (1996).
3. Feil, R., Wagner, J., Metzger, D. & Chambon, P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237, 752–757, doi: 10.1006/bbrc.1997.7124 (1997).
4. Feil, S., Valtcheva, N. & Feil, R. Inducible Cre mice. Methods Mol Biol 530, 343–363, doi: 10.1007/978-1-59745-471-1_18 (2009).
5. Robinson, S. P., Langan-Fahey, S. M., Johnson, D. A. & Jordan, V. C. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos 19, 36–43 (1991).
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献